Researchers at the University of Queensland are making significant strides toward developing a groundbreaking topical cream to prevent and treat skin cancers, specifically in organ transplant ...

Researchers from the UCLA Health Jonsson Comprehensive Cancer Center and The University of Texas MD Anderson Cancer Center have demonstrated that a novel topical ... in the skin that anti-EGFR ...

LUT014 works by paradoxically reactivating MAPK, a key signaling pathway in the skin that anti-EGFR therapies shut down.

Researchers from the UCLA Health Jonsson Comprehensive Cancer Center and The University of Texas MD Anderson Cancer Center have demonstrated that a novel topical ... in the skin that anti-EGFR ...

A new topical ... cancer commonly are treated with anti‐EGFR therapies, such as cetuximab and panitumumab. However, EGFR inhibition blocks the MAPK pathway, disrupting normal skin cell function ...

With light treatment, using Metvix cream, there is a 95 per cent first-time success rate." Not all skin cancers can be moved using light treatment. At present, PDT will only go to a certain depth ...

Clascoterone cream 1% used twice daily for 2 weeks had no effect on transepidermal water loss of the skin barrier and ...

A topical cream to help prevent and treat skin cancers in organ transplant patients is a step closer to development. The world-first treatment, currently being developed by University of ...

The International League of Dermatological Societies has released an updated position statement on the use of topical corticosteroids ... “The development of skin cancer has also been reported.” ...

Novel treatment allowed patients with colorectal cancer to successfully continue taking their cancer treatment with improved quality of life. Acne-like skin rash is a common side effect from ...

Researchers from the UCLA Health Jonsson Comprehensive Cancer Center and The University of Texas MD Anderson Cancer Center have demonstrated that a novel topical ... in the skin that anti-EGFR ...